13G Filing: Tappan Street Partners and Peregrine Pharmaceuticals Inc (PPHM)

You can access the original SEC filing by clicking here.

Ownership Summary Table

Name Sole Voting Power Shared Voting Power Sole Dispositive Power Shared Dispositive Power Aggregate Amount Owned Power Percent of Class
Tappan Street Partners 0 2,231,577 0 2,231,577 2,231,577 4.95%
Tappan Street Partners Fund 0 1,540,000 0 1,540,000 1,540,000 3.42%
Tappan Street Partners Ideas Fund 0 691,577 0 691,577 691,577 1.53%
Prasad Phatak 67,107 2,231,577 67,107 2,231,577 2,298,684 5.10%
Prasad Phatak And Chris Koranda
Prasad Phatak And Chris Koranda
Tappan Street Partners

Page 1 of 9 – SEC Filing

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

SCHEDULE 13G

Under
the Securities Exchange Act of 1934*

(Amendment
No. 1)

 

 
Peregrine
Pharmaceuticals, Inc.

(Name
of Issuer)

 

Common
Stock ($0.001 par value)

(Title
of Class of Securities)

 

713661502

(CUSIP
Number)

 

July
11, 2017
(Date
of Event Which Requires Filing of this Statement)

Check
the appropriate box to designate the rule pursuant to which this Schedule is filed:

  Rule
13d-1(b)
     
  Rule
13d-1(c)
     
  Rule
13d-1(d)

*
The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to
the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided
in a prior cover page.

The
information required in the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section
18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act
but shall be subject to all other provisions of the Act (however, see the Notes).

Follow Avid Bioservices Inc. (NASDAQ:CDMO)